tpn electrolytes

Generic: sodium chloride, calcium chloride, potassium chloride, magnesium chloride, and sodium acetate anhydrous

Labeler: hospira, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name tpn electrolytes
Generic Name sodium chloride, calcium chloride, potassium chloride, magnesium chloride, and sodium acetate anhydrous
Labeler hospira, inc.
Dosage Form INJECTION, SOLUTION, CONCENTRATE
Routes
INTRAVENOUS
Active Ingredients

calcium chloride 331 mg/20mL, magnesium chloride 508 mg/20mL, potassium chloride 1491 mg/20mL, sodium acetate anhydrous 2420 mg/20mL, sodium chloride 321 mg/20mL

Manufacturer
Hospira, Inc.

Identifiers & Regulatory

Product NDC 0409-5779
Product ID 0409-5779_44cabde0-b34c-4254-9a02-6e26de9a92fe
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA018895
Listing Expiration 2026-12-31
Marketing Start 2005-02-28

Pharmacologic Class

Classes
blood coagulation factor [epc] calcium [cs] calculi dissolution agent [epc] cations divalent [cs] increased coagulation factor activity [pe] increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] inhibition small intestine fluid/electrolyte absorption [pe] magnesium ion exchange activity [moa] osmotic activity [moa] osmotic laxative [epc] phosphate binder [epc] phosphate chelating activity [moa] potassium compounds [cs] potassium salt [epc] stimulation large intestine fluid/electrolyte secretion [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 04095779
Hyphenated Format 0409-5779

Supplemental Identifiers

RxCUI
801451
UNII
M4I0D6VV5M 02F3473H9O 660YQ98I10 NVG71ZZ7P0 451W47IQ8X

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tpn electrolytes (source: ndc)
Generic Name sodium chloride, calcium chloride, potassium chloride, magnesium chloride, and sodium acetate anhydrous (source: ndc)
Application Number NDA018895 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 331 mg/20mL
  • 508 mg/20mL
  • 1491 mg/20mL
  • 2420 mg/20mL
  • 321 mg/20mL
source: ndc
Packaging
  • 25 VIAL, SINGLE-DOSE in 1 CARTON (0409-5779-01) / 20 mL in 1 VIAL, SINGLE-DOSE (0409-5779-11)
source: ndc

Packages (1)

0409-5779-01 25 VIAL, SINGLE-DOSE in 1 CARTON (0409-5779-01) / 20 mL in 1 VIAL, SINGLE-DOSE (0409-5779-11)

Ingredients (5)

calcium chloride (331 mg/20mL) magnesium chloride (508 mg/20mL) potassium chloride (1491 mg/20mL) sodium acetate anhydrous (2420 mg/20mL) sodium chloride (321 mg/20mL)

Linked Drug Pages (1)

TPN Electrolytes ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "44cabde0-b34c-4254-9a02-6e26de9a92fe", "openfda": {"unii": ["M4I0D6VV5M", "02F3473H9O", "660YQ98I10", "NVG71ZZ7P0", "451W47IQ8X"], "rxcui": ["801451"], "spl_set_id": ["c00817bc-7b62-4abe-0280-e7930eda3f94"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (0409-5779-01)  / 20 mL in 1 VIAL, SINGLE-DOSE (0409-5779-11)", "package_ndc": "0409-5779-01", "marketing_start_date": "20050228"}], "brand_name": "TPN Electrolytes", "product_id": "0409-5779_44cabde0-b34c-4254-9a02-6e26de9a92fe", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "pharm_class": ["Blood Coagulation Factor [EPC]", "Calcium [CS]", "Calculi Dissolution Agent [EPC]", "Cations", "Divalent [CS]", "Increased Coagulation Factor Activity [PE]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]", "Magnesium Ion Exchange Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Phosphate Binder [EPC]", "Phosphate Chelating Activity [MoA]", "Potassium Compounds [CS]", "Potassium Salt [EPC]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "0409-5779", "generic_name": "SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, and SODIUM ACETATE ANHYDROUS", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TPN Electrolytes", "active_ingredients": [{"name": "CALCIUM CHLORIDE", "strength": "331 mg/20mL"}, {"name": "MAGNESIUM CHLORIDE", "strength": "508 mg/20mL"}, {"name": "POTASSIUM CHLORIDE", "strength": "1491 mg/20mL"}, {"name": "SODIUM ACETATE ANHYDROUS", "strength": "2420 mg/20mL"}, {"name": "SODIUM CHLORIDE", "strength": "321 mg/20mL"}], "application_number": "NDA018895", "marketing_category": "NDA", "marketing_start_date": "20050228", "listing_expiration_date": "20261231"}